Novartis Ireland Limited — 47 Licensed Medicines in Ireland

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

← All medicines · 47 products held by Novartis Ireland Limited

Medicine	Active substance	Licence holder	Status
Cataflam 50mg Coated Tablets PA0896/004/001	Diclofenac potassium	Novartis Ireland Limited	Marketed
Certican 0.25mg Tablets PA0896/005/001	Everolimus	Novartis Ireland Limited	Not marketed
Certican 0.75mg Tablets PA0896/005/003	Everolimus	Novartis Ireland Limited	Not marketed
Ciloxan 3 mg/ml ear drops, solution PA0896/006/001	Ciprofloxacin	Novartis Ireland Limited	Marketed
Co-Diovan 160 mg/12.5 mg film-coated tablets PA0896/007/002	Valsartan, Hydrochlorothiazide	Novartis Ireland Limited	Marketed
Co-Diovan 160 mg/25 mg film-coated tablets PA0896/007/003	Valsartan, Hydrochlorothiazide	Novartis Ireland Limited	Marketed
Co-Diovan 320 mg/12.5 mg film-coated tablets PA0896/007/004	Valsartan, Hydrochlorothiazide	Novartis Ireland Limited	Marketed
Co-Diovan 320 mg/25 mg film-coated tablets PA0896/007/005	Valsartan, Hydrochlorothiazide	Novartis Ireland Limited	Marketed
Co-Diovan 80 mg/12.5 mg film-coated tablets PA0896/007/001	Valsartan, Hydrochlorothiazide	Novartis Ireland Limited	Marketed
Diovan 160 mg film-coated tablets PA0896/009/002	Valsartan	Novartis Ireland Limited	Marketed
Diovan 320 mg film-coated tablets PA0896/009/004	Valsartan	Novartis Ireland Limited	Marketed
Diovan 3mg/ml oral solution PA0896/009/005	Valsartan	Novartis Ireland Limited	Marketed
Diovan 40 mg film-coated tablets PA0896/009/003	Valsartan	Novartis Ireland Limited	Marketed
Diovan 80 mg film-coated tablets PA0896/009/001	Valsartan	Novartis Ireland Limited	Marketed
Femara 2.5 mg film-coated tablets PA0896/012/001	Letrozole	Novartis Ireland Limited	Not marketed
Lamisil 250 mg tablets PA0896/015/001	Terbinafine	Novartis Ireland Limited	Not marketed
Lioresal 10 mg Tablets PA0896/017/001	Baclofen	Novartis Ireland Limited	Marketed
Lioresal 5mg/5ml Oral solution PA0896/017/002	Baclofen	Novartis Ireland Limited	Marketed
Luxturna 5 × 1012 vector genomes/mL concentrate and solvent for solution for injection EU/1/18/1331/001	VORETIGENE NEPARVOVEC	Novartis Ireland Limited	—
Maxidex 0.1% w/v Eye Drops, Suspension PA0896/018/001	Dexamethasone	Novartis Ireland Limited	Marketed
Maxitrol 0.1% w/v, 6000 IU/ml, 3500 IU/ml eye drops, suspension PA0896/019/001	Dexamethasone, Polymyxin b sulfate, Neomycin sulfate	Novartis Ireland Limited	Not marketed
Myfortic 180 mg gastro-resistant tablets PA0896/023/001	Mycophenolic acid	Novartis Ireland Limited	Marketed
Myfortic 360 mg gastro-resistant tablets PA0896/023/002	Mycophenolic acid	Novartis Ireland Limited	Marketed
Neoral 100 mg/ml concentrate for oral solution PA0896/024/004	Ciclosporin	Novartis Ireland Limited	Marketed
Neoral 100mg Soft Capsules PA0896/024/003	Ciclosporin	Novartis Ireland Limited	Marketed
Neoral 25 mg Soft Capsules PA0896/024/001	Ciclosporin	Novartis Ireland Limited	Marketed
Neoral 50mg Soft Capsules PA0896/024/002	Ciclosporin	Novartis Ireland Limited	Marketed
Sandimmun 50 mg/ml Concentrate for Solution for Infusion PA0896/027/002	Ciclosporin	Novartis Ireland Limited	Marketed
SANDOSTATIN 100 microgram/1ml, solution for injection/infusion PA0896/028/002	Octreotide	Novartis Ireland Limited	Marketed
SANDOSTATIN 50 microgram/1 ml, solution for injection/infusion PA0896/028/001	Octreotide	Novartis Ireland Limited	Marketed
SANDOSTATIN 500 microgram/1 ml, solution for injection/infusion PA0896/028/003	Octreotide	Novartis Ireland Limited	Marketed
Sandostatin LAR 10 mg powder and solvent for suspension for injection PA0896/028/004	Octreotide	Novartis Ireland Limited	Marketed
Sandostatin LAR 20 mg powder and solvent for suspension for injection PA0896/028/005	Octreotide	Novartis Ireland Limited	Marketed
Sandostatin LAR 30 mg powder and solvent for suspension for injection PA0896/028/006	Octreotide	Novartis Ireland Limited	Marketed
Tegretol 100mg Tablets PA0896/030/002	Carbamazepine	Novartis Ireland Limited	Marketed
Tegretol 100mg/5ml Oral Suspension PA0896/030/001	Carbamazepine	Novartis Ireland Limited	Marketed
Tegretol 200mg Tablets PA0896/030/003	Carbamazepine	Novartis Ireland Limited	Marketed
Tegretol 400mg Tablets PA0896/030/004	Carbamazepine	Novartis Ireland Limited	Marketed
Tegretol SR 200mg prolonged release tablets PA0896/030/005	Carbamazepine	Novartis Ireland Limited	Marketed
Tegretol SR 400mg prolonged release tablets PA0896/030/006	Carbamazepine	Novartis Ireland Limited	Marketed
Trileptal 150 mg Film-coated tablets PA0896/033/001	Oxcarbazepine	Novartis Ireland Limited	Marketed
Trileptal 300 mg Film-coated tablets PA0896/033/002	Oxcarbazepine	Novartis Ireland Limited	Marketed
Trileptal 60 mg/ml Oral Suspension PA0896/033/004	Oxcarbazepine	Novartis Ireland Limited	Marketed
Trileptal 600 mg Film-coated tablets PA0896/033/003	Oxcarbazepine	Novartis Ireland Limited	Marketed
Voltarol 50 mg Gastro-Resistant Tablets PA0896/034/001	Diclofenac sodium	Novartis Ireland Limited	Marketed
Voltarol Retard 100 mg Film-coated Prolonged Release Tablets PA0896/034/002	Diclofenac sodium	Novartis Ireland Limited	Marketed
Voltarol Retard 75 mg Film-coated Prolonged-release Tablets PA0896/034/003	Diclofenac sodium	Novartis Ireland Limited	Marketed

Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.

Novartis Ireland Limited — Licensed Medicines